{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:58:54Z","timestamp":1791007134575,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/leu.2012.23","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T11:39:35Z","timestamp":1328614775000},"page":"1507-1516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases"],"prefix":"10.1038","volume":"26","author":[{"given":"J-Q","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-J","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X-X","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-F","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-H","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-H","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-Y","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-J","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-Y","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-G","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F-Y","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-M","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z-X","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"key":"BFleu201223_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","volume":"144","author":"CJ Harrison","year":"2009","unstructured":"Harrison CJ . Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 2009; 144: 147\u2013156.","journal-title":"Br J Haematol"},{"key":"BFleu201223_CR2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1470-2045(09)70369-9","volume":"11","author":"T Szczepanski","year":"2010","unstructured":"Szczepanski T, Harrison CJ, van Dongen JJ . Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol 2010; 11: 880\u2013889.","journal-title":"Lancet Oncol"},{"key":"BFleu201223_CR3","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"key":"BFleu201223_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/leu.2010.228","volume":"25","author":"S Mizuta","year":"2011","unstructured":"Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y et al. Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. Leukemia 2011; 25: 41\u201347.","journal-title":"Leukemia"},{"key":"BFleu201223_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1182\/blood-2005-11-4386","volume":"108","author":"B Wassmann","year":"2006","unstructured":"Wassmann B, Pfeifer H, Goekbuget N, Beelen DW, Beck J, Stelljes M et al. Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood 2006; 108: 1469\u20131477.","journal-title":"Blood"},{"key":"BFleu201223_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","volume":"11","author":"AV Moorman","year":"2010","unstructured":"Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial. Lancet Oncol 2010; 11: 429\u2013438.","journal-title":"Lancet Oncol"},{"key":"BFleu201223_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/leu.2010.275","volume":"25","author":"E Waanders","year":"2011","unstructured":"Waanders E, van der Velden VH, van der Schoot CE, van Leeuwen FN, van Reijmersdal SV, de Haas V et al. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia 2011; 25: 254\u2013258.","journal-title":"Leukemia"},{"key":"BFleu201223_CR8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/leu.2010.87","volume":"24","author":"RP Kuiper","year":"2010","unstructured":"Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, Scheijen B et al. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 2010; 24: 1258\u20131264.","journal-title":"Leukemia"},{"key":"BFleu201223_CR9","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","volume":"27","author":"G Martinelli","year":"2009","unstructured":"Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 2009; 27: 5202\u20135207.","journal-title":"J Clin Oncol"},{"key":"BFleu201223_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1182\/blood-2010-07-297135","volume":"117","author":"HM Ensor","year":"2011","unstructured":"Ensor HM, Schwab C, Russell LJ, Richards SM, Morrison H, Masic D et al. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. Blood 2011; 117: 2129\u20132136.","journal-title":"Blood"},{"key":"BFleu201223_CR11","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","volume":"115","author":"RC Harvey","year":"2010","unstructured":"Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 2010; 115: 5312\u20135321.","journal-title":"Blood"},{"key":"BFleu201223_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009; 360: 470\u2013480.","journal-title":"N Engl J Med"},{"key":"BFleu201223_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/ng.469","volume":"41","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Collins-Underwood JR, Phillips LA, Loudin MG, Liu W, Zhang J et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet 2009; 41: 1243\u20131246.","journal-title":"Nat Genet"},{"key":"BFleu201223_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451\u2013458.","journal-title":"Br J Haematol"},{"issue":"7","key":"BFleu201223_CR15","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/leu.2012.26","volume":"26","author":"B Chen","year":"2012","unstructured":"Chen B, Wang Y-Y, Shen Y, Zhang W-N, He H-Y, Zhu Y-M et al. Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries. Leukemia 2012; e-pub ahead of print 2 March 2012; doi:10.1038\/leu.2012.26.","journal-title":"Leukemia"},{"key":"BFleu201223_CR16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1182\/blood.V92.2.574","volume":"92","author":"N Pallisgaard","year":"1998","unstructured":"Pallisgaard N, Hokland P, Riishoj DC, Pedersen B, Jorgensen P . Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998; 92: 574\u2013588.","journal-title":"Blood"},{"key":"BFleu201223_CR17","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1158\/1078-0432.CCR-05-2832","volume":"12","author":"YM Zhu","year":"2006","unstructured":"Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J et al. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res 2006; 12: 3043\u20133049.","journal-title":"Clin Cancer Res"},{"key":"BFleu201223_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1182\/blood-2002-09-2913","volume":"102","author":"V Asnafi","year":"2003","unstructured":"Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 2003; 102: 1000\u20131006.","journal-title":"Blood"},{"key":"BFleu201223_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bcmd.2008.06.006","volume":"41","author":"AN Meleshko","year":"2008","unstructured":"Meleshko AN, Movchan LV, Belevtsev MV, Savitskaja TV . Relative expression of different Ikaros isoforms in childhood acute leukemia. Blood Cells Mol Dis 2008; 41: 278\u2013283.","journal-title":"Blood Cells Mol Dis"},{"key":"BFleu201223_CR20","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","volume":"115","author":"G Cario","year":"2010","unstructured":"Cario G, Zimmermann M, Romey R, Gesk S, Vater I, Harbott J et al. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood 2010; 115: 5393\u20135397.","journal-title":"Blood"},{"key":"BFleu201223_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1073\/pnas.0911726107","volume":"107","author":"A Yoda","year":"2010","unstructured":"Yoda A, Yoda Y, Chiaretti S, Bar-Natan M, Mani K, Rodig SJ et al. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2010; 107: 252\u2013257.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201223_CR22","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","volume":"114","author":"LJ Russell","year":"2009","unstructured":"Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 2009; 114: 2688\u20132698.","journal-title":"Blood"},{"key":"BFleu201223_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1080\/10428190701784730","volume":"49","author":"LJ Gu","year":"2008","unstructured":"Gu LJ, Li J, Xue HL, Tang JY, Chen J, Zhao HJ et al. Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leuk Lymphoma 2008; 49: 488\u2013494.","journal-title":"Leuk Lymphoma"},{"key":"BFleu201223_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/pbc.22127","volume":"53","author":"Y Liu","year":"2009","unstructured":"Liu Y, Chen J, Tang J, Ni S, Xue H, Pan C . Cost of childhood acute lymphoblastic leukemia care in Shanghai, China. Pediatr Blood Cancer 2009; 53: 557\u2013562.","journal-title":"Pediatr Blood Cancer"},{"key":"BFleu201223_CR25","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","volume":"114","author":"DI Marks","year":"2009","unstructured":"Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, DeWald G et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993). Blood 2009; 114: 5136\u20135145.","journal-title":"Blood"},{"key":"BFleu201223_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE . Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166\u2013178.","journal-title":"N Engl J Med"},{"key":"BFleu201223_CR27","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/1097-0142(19951215)76:12<2393::AID-CNCR2820761203>3.0.CO;2-P","volume":"76","author":"JE Cortes","year":"1995","unstructured":"Cortes JE, Kantarjian HM . Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 1995; 76: 2393\u20132417.","journal-title":"Cancer"},{"key":"BFleu201223_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"CH Pui","year":"1998","unstructured":"Pui CH, Evans WE . Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605\u2013615.","journal-title":"N Engl J Med"},{"key":"BFleu201223_CR29","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","volume":"103","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, Faderl S, Cortes J, O\u2019Brien S, Giles FJ, Kornblau SM et al. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 2004; 103: 4396\u20134407.","journal-title":"Blood"},{"key":"BFleu201223_CR30","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","volume":"109","author":"A de Labarthe","year":"2007","unstructured":"de Labarthe A, Rousselot P, Huguet-Rigal F, Delabesse E, Witz F, Maury S et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood 2007; 109: 1408\u20131413.","journal-title":"Blood"},{"key":"BFleu201223_CR31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","volume":"21","author":"N Boissel","year":"2003","unstructured":"Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003; 21: 774\u2013780.","journal-title":"J Clin Oncol"},{"key":"BFleu201223_CR32","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1200\/JCO.2008.20.8959","volume":"27","author":"JB Nachman","year":"2009","unstructured":"Nachman JB, La MK, Hunger SP, Heerema NA, Gaynon PS, Hastings C et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group. J Clin Oncol 2009; 27: 5189\u20135194.","journal-title":"J Clin Oncol"},{"key":"BFleu201223_CR33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","volume":"24","author":"M Yanada","year":"2006","unstructured":"Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F et al. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 2006; 24: 460\u2013466.","journal-title":"J Clin Oncol"},{"key":"BFleu201223_CR34","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/sj.leu.2403886","volume":"19","author":"KH Lee","year":"2005","unstructured":"Lee KH, Lee JH, Choi SJ, Seol M, Lee YS, Kim WK et al. Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 2005; 19: 1509\u20131516.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201223","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:15:37Z","timestamp":1648739737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFleu201223"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.23","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]},"assertion":[{"value":"16 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}